Chronic myelogenous leukemia clinical practice guidelines in oncology

J Natl Compr Canc Netw. 2003 Jan:1 Suppl 1:S14-28.

Authors

Susan O'Brien¹; National Comprehensive Cancer Network

Affiliation

¹ University of Texas M. D. Anderson Cancer Center, USA.

PMID: 19795573

No abstract available

Publication types

Practice Guideline

MeSH terms

Antineoplastic Agents / therapeutic use
Benzamides
Hematopoietic Stem Cell Transplantation
Humans
Imatinib Mesylate
Interferon-alpha / therapeutic use
Karyotyping
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
Piperazines / therapeutic use
Pyrimidines / therapeutic use

Substances

Antineoplastic Agents
Benzamides
Interferon-alpha
Piperazines
Pyrimidines
Imatinib Mesylate